Skip to main content

Getinge Value Stock - Dividend - Research Selection

Getinge AB Series B

ISIN: SE0000202624, WKN: 889714

Market price date: 26.01.2022
Market price: 335,80 SEK


Getinge AB Series B Fundamental data and company key figures of the share

Annual reports in SEK
Key figures 18-09-2021
Cash flow
Net operating cash flow 7.199.000.000
Capital Expenditures -437.000.000
Free cash flow 6.761.999.872
Balance sheet
Total Equity 21.024.000.000
Liabilities & Shareholders equity 45.014.000.000
Income statement
Net income 3.238.000.000
Eps (diluted) 11,888
Diluted shares outstanding 272.370.000
Net sales/revenue 29.819.000.000

Fundamental ratios calculated on: 26-01-2022

Ratios
Key figures 26-01-2022
Cash flow
P/C 12,71
   
P/FC 13,53
Balance sheet
ROI7,19
ROE46,71
Income statement
P/E28,25
Div. Yield0,89%
P/B4,35
P/S3,07


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolGETI-B.ST
Market Capitalization10.314.043.392,00 USD
CountrySweden
IndicesSTOXX EUROPE 600
SectorsHealth Care Equipment
Raw Data SourceIFRS in Millionen SEK
Stock Split2017-08-24,1399.000000/1379.000000; 2008-11-26,581.000000/570.000000; 2008-02-26,961.000000/947.000000; 2003-11-27,4.000000/1.000000
Internetwww.getinge.com


Description of the company

Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgery and life sciences in the hospital, pharmaceutical and research sectors. The company reports in three segments: Acute Therapies (63% of sales), Surgical Workflows (27%) and Life Sciences (10%). Product areas include ventilators, surgical stents, life support systems, sterilizers, operating tables and sterile transfer systems. Getinge generates its sales from a broad geographic presence, with the Americas accounting for 45% of sales (33% of sales in the US), 25% in the Asia-Pacific region and the remaining 30% in Europe, the Middle East and Africa.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.getinge.com


NEWS